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Abstract Adults with Down syndrome (DS) are at a very
high risk of developing early onset Alzheimer’s disease
(AD) due to trisomy of chromosome 21. AD is preceded by
a prolonged prodromal Bpre-clinical^ phase presenting with
clinical features that do not fulfil the diagnostic criteria for
AD. It is important to clinically characterise this prodromal
stage to help early detection of the disease as neuropathology
of AD is almost universal by the fifth decade in DS. There is a
lack of knowledge of the trajectory of decline associated with
the onset of dementia in this population and early signs may
be overlooked or misdiagnosed, negatively affecting the qual-
ity of life of those affected and the use of early pharmacolog-
ical or psychosocial interventions. The objective of this sys-
tematic review is to evaluate the published literature on lon-
gitudinal data in order to identify the cognitive and behaviour-
al changes occurring during the prodromal and early stages of
AD in this population. Fifteen peer-reviewed articles met the
inclusion criteria, including a total number of 831 participants,
with the duration between baseline and follow up varying
from 1 year to 47 years. Results suggest that, compared to
the general population for which short-term (episodic) mem-
ory loss is the most common indicator associated with the
onset of AD, in people with DS, executive dysfunction and
Behavioural and Psychological Symptoms of Dementia
(BPSD) are commonly observed during pre-clinical and early
stages and may precede memory loss. The review highlights
the importance of using a broad spectrum of assessments in
the context of heterogeneity of symptoms. Theoretical and
practical implications are discussed, as well as the need for
further research.
Keywords Down syndrome . Alzheimer’s disease .
Dementia . Ageing . Systematic review . Longitudinal
Background
Alzheimer’s disease (AD) is a neurodegenerative disorder
characterized histopathologically by neuronal death, neuritic
plaques and neurofibrillary tangles and clinically by a progres-
sive and irreversible deterioration in cognition and behaviour
(McKhann et al. 2011). The greatest prevalence of early onset
AD is found in individuals with Down Syndrome (DS), with
symptoms appearing before the age of 65 (Hartley et al. 2014)
and approximately three-quarters of people with DS over 60
showing clinical evidence of dementia (Lai and Williams
1989). As the life expectancy of people with DS has increased
from an estimated mean of 12 years in 1940, to over 60 years
now (Bittles and Glasson 2004), the focus of research and of
clinical services now includes adulthood and later life.
The later stages of AD in people with DS have been doc-
umented and are reportedly similar to symptoms exhibited by
people with AD in the general population (Strydom et al.
2010). However, limited information is available with regards
to cognitive and behavioural changes prior to diagnosis or
during the very early stages (Adams and Oliver 2010).
While in the general population the prodromic stage of AD
is characterized by impairments in episodic memory, a num-
ber of qualitative studies involving people with DS have sug-
gested that the progression of AD in people with DS (DSAD)
might be more similar to dementia of the frontal type in the
typically developing population, with Behavioural and
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Psychological Symptoms of Dementia (BPSD) and impair-
ment of executive functions (i.e. goal directed behaviours such
as planning, attention, judgement etc.) preceding memory
impairments (Deb et al. 2007).
Previous research has also indicated that carers often lack
basic knowledge regarding the risk for dementia in this pop-
ulation and are not aware of the symptoms that they should be
vigilant for in ageing individuals (Bittles and Glasson 2004).
The present paper aims to address this gap in the literature and
we report findings from a systematic review of the trajectory
of changes that accompany the onset of dementia in this pop-
ulation (i.e. before the formal diagnostic criteria of AD are
fulfilled). If there is evidence for an atypical presentation of
dementia, such as BPSD and executive dysfunction preceding
the development of sufficient symptoms to meet the diagnos-
tic criteria of dementia, this might partially account for the
discrepancy between the almost universal presence of neuro-
pathology from age 40 years onwards and the lower (than
expected) prevalence rates for clinically diagnosed dementia
(Ball et al. 2006) given the prevalence rate of neuropathology.
Identifying symptoms that characterize pre-clinical and early
AD in people with DS is necessary before further research and
clinical interventions, which link findings from neuropathol-
ogy, putative biomarkers or neuroimaging (Annus et al. 2015)
with cognitive features, can be undertaken. Lastly, as new
pharmaceutical therapies are developed it is necessary to have
reliable measures of performance in all relevant outcome do-
mains so that effectiveness of treatments can be evaluated.
Methods
A systematic review was undertaken following the guidelines
provided by PRISMA (i.e. Preferred Reporting Items for
Systematic Reviews and Meta-Analyses: http://www.prisma-
statement.org/) and the Cochrane Collaboration (http://www.
cochrane.org/). Potentially relevant studies were identified
through searches in citation indexing databases: PubMed
(Medline) and PsycInfo, as it has been suggested that they provide
broad coverage of biomedical publications worldwide (Suarez-
Almazor et al. 2000). Within the electronic database, the search
was limited to peer-reviewed journals published between 2000
and 21.01.2015 and included the following terms ((BDown
s y n d r o m e ^[ T i t l e / A b s t r a c t ] O R BD o w n ^s
syndrome^[Title/Abstract])) AND (BAlzheimer^[Title/Abstract]
O R BA l z h e i m e r ^s ^[ T i t l e / A b s t r a c t ] O R
Bdementia^[Title/Abstract]). The search delivered 1267 results
and reference lists of selected papers were also searched for
potentially relevant studies (Fig. 1).
Titles and abstracts, and then full text articles were
reviewed to identify and exclude studies that did not satisfy
the previously established criteria: (a) empirical papers, (b)
n > 1 (c) specified diagnosis of DS, and (d) specific reference
to the clinical presentation of early stages of DSAD.
Longitudinal studies were chosen as this type of study over-
comes the issue of cohort effects and allows a better under-
standing of the dynamic process of cognitive and behavioural
change. To minimize bias, the first author discussed the eligi-
bility and validity of included studies with another member of
the research team (AJH), solving any disagreement by
consensus.
Moreover, as authors of the included studies have used a
large variety of terms to refer to the same concept (i.e.
Bpersonality changes^, Bbehavioural change^, Bbehavioural
excesses and deficits^, Bmaladaptive behaviour^), we will be
using the umbrella term Behavioural and Psychological
Symptoms of Dementia (BPSD) in order to enhance the over-
all consistency of the paper.
Results
In total, 15 papers reporting on 15 longitudinal studies were
selected for data extraction and analysis. Data was collected
following guidelines set by the Cochrane Collaboration, with
the following variables being extracted: study length, partici-
pant number and age at each assessment (mean and standard
deviation, if recorded), dementia diagnosis, assessment mea-
sures and reported progression of symptoms. In cases where
the longitudinal aspect was part of a larger cross-sectional
study, data were included only from participants for which at
least 2 data points were available. Summary statistics (mean
ages and percentages) were calculated where they were not
explicitly stated by authors. The duration between baseline
and follow up varied from 1 year to 47 years and included a
total of 831 participants.
A brief analysis of bias was conducted on the included
studies by examining the degree to which the sampling frame
is representative of the general population and whether the
assessment tools have been validated, as well as the response
proportion at both baseline and follow up, with minimal risks
1267 records idenﬁed through 
database searching
2 addional records idenﬁed 
through other sources
1123 records aer duplicates 
removed
1123 records screened 1069 records excluded
54 full-text arcles assessed for 
eligibility
15 studies included
39 full-text arcles excluded 
Not longitudinal (n = 30)
Ineligible populaon (n = 3)
Not referring to early signs (n = 5)
Same sample as other study (n = 1)
Fig. 1 Flow chart showing the process of selecting studies to be included
in systematic review
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of bias being identified by the authors. Table 1 uses Crombie’s
Items (Zeng et al. 2015) and the reporting format suggested by
the Cochrane Collaboration in order to identify possible areas
of bias.
It is also worth mentioning that some of the included
studies have overlapping authors (e.g. Kitler et al. 2006;
Krinsky-McHale et al. 2002; Devenny et al. 2000; Urv
et al. 2008; and Ball et al. 2006; Holland et al. 2000)
and since these are longitudinal studies conducted during
the same time period, it is likely that some participants
overlap within each group, which might impact the over-
all review.
For each study the following specific aspects were consid-
ered: first, evidence for change between time points in scores
on cognitive functioning and, secondly, the reported BPSD
identified as part of the diagnostic assessment. Where possi-
ble, the relationship between these observed changes over
time was evaluated. Considering that the length of follow-
up, diagnosis reports and assessment methods varied consid-
erably (8 methods of diagnosing dementia, 10 memory tests,
21 instruments for assessing executive dysfunction and 10
measures of behaviour change (Table 2), the results are de-
scribed through a qualitative synthesis rather than a meta-
analysis.
Presentation and Progression of Dementia in the People
with DS
In the general population, mild cognitive impairment (MCI) is
regarded as the prodromal stage of dementia, but it has been
Table 1 Risk of bias
Appropriateness
of design to
meet the aims
Adequate
description
of the data
Report
the
response
rates
Adequate
representativeness
of the sample to
total
Clearly stated
aims and
likelihood of
reliable and valid
measurements
Assessment
of statistical
significance
Adequate
description
of
statistical
methods
Comment
Ball et al. 2006 + + + + + + +
Adams & Oliver
2010
+ ? + + + + + Insufficient
information on
diagnosis rates
at T1
Kitler et al. 2006 + + + + + + +
Temple et al.
2001
+ ? + + + + + Insufficient
information on
diagnostic rates at
T1
Carr and Collins
2014
? + + − + + + Insufficient details on
diagnostic
procedure. All
female sample
Cosgrave et al.
2000
+ + + + + + +
Krinsky-McHale
et al. 2002
+ + + + + + +
Nelson et al.
2007
+ + + + + + +
Margallo-Lana
et al. 2007
− + + + + + + Different screening
procedures used
based on
availability of
information & level
of ID
McCarron
et al.2014
+ ? + − + + Insufficient
information on
diagnostic rates at
T1. All female
sample
Makary et al.
2014
+ + + + + + +
Holland et al.
2000
+ + + + + + +
Devenny et al.
2000
+ + + + + + +
Urv et al. 2008 + + + + + + +
Määttä et al.
2014
+ + + + + + +
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argued that, in the case of people with DS, the exact hierarchy
of loss of function is very difficult to establish (Cosgrave et al.
2000). Out of the 15 studies identified here, which attempted
to address this question, nine suggested that ‘frontal-like
symptoms’ were the earliest sign of AD in this population.
Only two studies reported memory as the earliest sign of
dementia. Out of the remaining four studies, two reported no
decline that could not be accounted for by normal ageing and
two did not report the order in which domains of cognitive
functioning were affected.
The studies reporting the progression of clinical signs of
DSAD are summarized in Table 3 and further discussed in the
following sections. It is important to note that the majority of
studies included in this review (with the exception of Määttä
et al. 2014) have used various screening tools, rather than a
diagnosis made by a clinician. Thus, it is possible that discrep-
ancies between results are due to inadequate classification of
participants with or without dementia, as well as due to the use
of different diagnostic methods in each individual study
(Ballard et al. 2016).
Table 2 Variety of assessments included in the systematic review
Abbreviation Assessment Developed by/
Reported in
AADS Assessment for adults with developmental disabilities Kalsy et al. 2002
ABD-Q Adaptive Behaviour Dementia Questionnaire Prasher et al. 2004
BEERY VMI Beery Visual Motor Integration test Beery and Buktenica
1997
BPVS British Picture Vocabulary Scale 2nd edition Dunn et al. 2009
CAMCOG Cognitive section of CAMDEX-DS Ball et al. 2004
CAMDEX-DS The Cambridge Examination for Mental Disorders of Older People with Down’s syndrome and Others with
Intellectual Disabilities
Ball et al. 2004
CRT Cued Recall Test Buschke 2008
DBC-A Developmental Behaviour Checklist-Adult Mohr 2004
DMR Dementia for Mentally Retarded Individuals Evenhuis 1990
DLSQ Daily Living Skills Questionnaire National Institute of
Ageing 1989
DSDS Dementia Scale for Down Syndrome Gedye 1995
DSMSE Down’s syndrome Mental Status Examination Haxby 1989
EF battery Tower of London Krikorian et al. 1994
Weigl card sorting Goldstein and Scheerer
1941
Cats and dogs Stroop task Gerstadt et al. 1994
Scrambled boxes Strauss and Lewin 1982
HBS Handicaps, behaviour and skills schedule Wing 1980
IBRMSE Institute for Basic Research Mental Status Exam Wisniewski and Hill
1985
LIPS Leiter International Performance Scale Leiter 1940
VABS Vineland Adaptive Behaviour Scale Sparrow et al. 1984
WRL Word List Recall Kittler et al. 2004
SRT Serial Reaction Time Buschke 1973
WPPSI-voc Vocabulary scale of Wechsler Pre-School and Primary Scale of Intelligence Wechsler 1967
NBAP-D Neuropsychology Behaviour and Affect Profile Nelson et al. 2007
Neuropsychological
battery
Boston Naming Test Kaplan 2001
Wide Range Achievement Test Jastak and Wilkinson
1984
Verbal fluency -
BPVS Dunn et al. 2009
Fuld Object-Memory test Fuld 1981
Visual Motor Integration Test Beery and Buktenica
1997
WISC-III Wechsler 1974
WPPSI Wechsler 1974
20-hole foam pegboard VABS - Sparrow et al. 1984
PPVT-4 Peabody Picture Vocabulary Test 4th Edition Dunn 2007
RBMT-C Rivermead Behavioural Memory Test for Children Wilson and
Ivani-Chalian 1995
RSMB Reiss Screen for Maladaptive Behaviour Reiss 1994
S-R paradigm Simple visual discrimination, reversal learning, Delayed non-match to sample, landmark Nelson et al. 2007
TSI Test for Severe Impairment Albert and Cohen 1992
WISC-R Wechsler Intelligence Scale for Children-Revised Wechsler 1974
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Memory
DS is known be associated with impairments in working
memory, specifically remembering information for short pe-
riods of time (Silverman 2007). It has been suggested that
tasks that rely on the hippocampus (e.g. associations of items
in space and time) are commonly impaired in this population,
hence making difficult the measurement of decline in these
domains as a marker of AD-related change. By taking into
account the level of baseline functioning, researchers interest-
ed in memory decline in people with DS have mostly focused
on verbal list learning and scene learning (Sabbagh and Edgin
2016).
Compared to the general population where episodic mem-
ory impairments characterize prodromal stages of AD in the
majority of cases, only two of the longitudinal studies includ-
ed in this review identified impairments in memory as one of
the earliest symptoms of DSAD (Krinsky-McHale et al. 2002;
Cosgrave et al. 2000). Krinsky-McHale et al. (2002) found
that decline in memory function scores preceded the onset of
global changes associated by the authors with the onset of
dementia, as reported in informant interviews. Decline in
memory function preceded more global changes by more than
a full year and in some cases by up to 3 years. More specifi-
cally, verbal explicit memory was one of the first domains that
were affected, with individuals’ scores on the Selective
Reminding Test declining by 20% on two consecutive test
sessions, The authors compared the results of participants with
dementia to those of age- and IQ-matched non-demented in-
dividuals with DS and concluded that the dramatic declines
observed in DSAD were distinguishable from normal ageing
pattern. Interestingly, even in cases where participants were
capable of performing the task, those in the early stages of
dementia showed deficits in their capacity to encode and re-
trieve information from long-term memory.
This view was supported by a previous study in which
memory loss was one of the first identifiable hallmarks of AD
in an all-female sample of older adults with DS (Cosgrave et al.
2000). In this study, participants had difficulty remembering
items that they had seen as part of a previous task (i.e. delayed
memory) and difficulty remembering in which hand a paper
clip was held by the examiner after both hands were placed
behind the examiner’s back (i.e. immediate memory).
However, these findings were only applicable in the case of
individuals with mild (IQ 55–70) and moderate ID (IQ 40–
55), and memory problems were more difficult to identify in
participants with more severe intellectual disabilities (severe =
IQ 25–40, or profound = IQ < 25) due to floor effects on
established tests. More specifically, participants with IQ under
40 had very low scores on memory tests regardless of demen-
tia diagnosis and thus, these measures may not be suitable as
an indicator of decline over time in this population. More
recently, in the DSM-V, IQ test scores have been removed
from the diagnostic criteria of ID (American Psychiatric
Association 2013), emphasizing the need for a more compre-
hensive assessment in which severity of ID will be based on
the level of adaptive functioning, rather than IQ, as the former
determines the level of support required (Oakley et al. 2003).
In the study conducted by Devenny et al. (2000), authors
suggested that decline does not occur globally but rather as a
systematic and progressive loss of cognitive functions, with
memory loss being a predominant symptom in all participants
who also showed decline on the Block Design and Coding
subtests of the WISC-R. These participants were classified as
having Bquestionable decline^. However, the authors empha-
size the fact that none of these participants had received an
official diagnosis from a physician and thus advise caution
when interpreting their results, as it is possible that the ob-
served declines were related to some other undetected
condition.
A different view, however, is that decline in memory scores
(even in the presence of developmental memory impairment)
are observed in all ageing individuals with DS, regardless of
dementia status (Ball et al. 2006; Devenny et al. 2000; Carr
and Collins 2014). It is possible that by examining alternative
measures of decline in other cognitive domains, the general-
ized pattern of deterioration that accompanies old age can be
distinguished from preclinical AD. In the study conducted by
Ball et al. (2006), informant reported memory changes were
not correlated with subsequent diagnosis of AD and all partic-
ipants who showed changes in memory also showed BPSD.
However, in people with DS, early changes in memory may
be more difficult to notice compared to BPSD, the latter hav-
ing a greater impact on the individual’s daily life (Adams and
Oliver 2010). Certain learning and memory tasks such as
cued-learning and recall tasks may prove to be of a greater
sensitivity and specificity for distinguishing between AD and
non-AD in this population (Benejam et al. 2015).
More recently, a review by Sabbagh and Edgin (2016),
suggested that the earliest symptoms of dementia in individ-
uals with DS are often subtle but are firstly evident in BPSD
rather than episodic memory. They are thus arguing that the
late diagnosis of DSAD is often due to the fact that current
classification systems have their emphasis on memory impair-
ments, having been modelled after the diagnostic criteria of
dementia in the general population and are unfit for use in the
DS population (Nieuwenhuis-Mark 2009).
Executive Function and Language
Functional impairments in executive functioning (executive
dysfunction), as referring to informant reported difficulties
with various goal-directed behaviours, such as planning and
attention, and also performance on specific cognitive tests,
have been identified in the majority of selected studies as
preceding memory problems in adults with DS. However, in
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the studies reviewed there was not obvious overlap in terms of
specific areas of decline identifed by repective authors. In Ball
et al. (2006), the most commonly reported changes were im-
pairments in planning, attention and lack of foresight, while in
another study (Adams and Oliver 2010), the most affected
areas were working memory, agnosia, aphasia and apraxia,
with cognitive deterioration not being solely attributable to
memory issues. In the Ball et al. (2006) paper, a version of
the CAMCOG neuropsychological test battery modified for
use with people with DSwas completed at baseline and follow
up assessments, to provide a measure of decline in global
cognitive function. To provide more specific information on
the sequence of decline in Bfrontal lobe associated EF^ over
the 5 years prior to diagnosis, an additional measure labelled
BEF and attention^ was designed by combining CAMCOG
scores for abstract thinking, attention-calculation, verbal flu-
ency and the clock drawing item. However, impairments in
planning and foresight were measured through informant re-
ported changes, rather than a more objective measure. Given
the variety of living situations of participants in this study [i.e.
residential homes (82%), sheltered accommodation (4%),
nursing homes (2%), with a parent orrelative (13%)], we ad-
vise caution when interpreting these results. The caution is
based on research showing that informant reports differ both
qualitatively and quantitatively when recorded from personnel
in an institution compared to parents (Nieuwenhuis-Mark
2009). Moreover, it is possible that Black of foresight^ could
be affected by intellectual ability and this should also be taken
into consideration, as 41 out of 55 participants in this study
had moderate or severe learning disability.
In one of the studies, executive dysfunction was investigat-
ed by looking at verbal intrusions as an indicator of disruption
of inhibition control (Kitler et al. 2006). Responding with an
irrelevant word during a task of verbal memory retrieval was
found to be predictive of performance on two out of three
memory tasks administered within the next three years.
Therefore, the authors argued that verbal intrusions are an
early sign of Alzheimer-related neuropathology, preceding de-
clines in memory. Interestingly, middle aged participants with
DS made more verbal intrusions at baseline compared to par-
ticipants with unspecified ID (74% vs 44%), giving further
support to the idea that executive functioning is more sensitive
to decline in DS than in other populations.
Another component of EF was examined by Nelson et al.
(2007), who identified the NBAP Pragnosia scale as useful in
classifying 80% of all dementia cases. The authors argued that
impaired pragmatic language function represents an aspect of
cognitive decline, as this measure appears to be strongly cor-
related with the assessment of dementia status (DMR
Cognitive Scale). These impairments appeared to be most
common in younger subjects, suggesting decline in functions
other than memory, early in the course of dementia. More
recently however, researchers have argued that verbal scores
do not show significant decrease over the course of 47 years
(Carr and Collins 2014), but these results might represent a
sample bias, as the stronger representation of verbally able
women might have influenced the overall stability of verbal
scores in the group.
However, the exact sequence in which subdomains of ex-
ecutive functioning are affected has not yet been established.
This could be largely due to the heterogeneity of DS pheno-
types. Devenny et al. (2000) attempted to answer this question
by following up participants over a 10 year period and noting
that scores which showed decline early in the disease process
were those that required perception of abstract stimuli and
visuo-motor coordination. As participants progressed from
prodromal stages to early dementia, deficits in comprehen-
sion, measures of visuospatial organization and the working
memory component of language were observed, followed by
vocabulary, information and digit span tasks in the middle
stages of AD. As decline associated with the development of
AD seems to involve progressively more areas of cognition
and the number of areas in which decline was observed of was
correlated to the severity of dementia, the authors conclude
that cognitive decline in AD in people with DS is not global,
but follows a predictable sequence. Executive functioning
seems, according to the evidence presented above, to be af-
fected in pre-clinical or early stages of AD and thus, detecting
these changes could prove to be helpful in predicting a later
diagnosis of AD.
Behavioural and Psychological Symptoms of Dementia
(BPSD)
Behavioural and Psychological Symptoms of Dementia
(BPSD) have been defined as a Bheterogeneous range of psy-
chological reactions, psychiatrics symptoms and behaviours
resulting from the presence of dementia^ (Finkel 2001).
Recent literature has suggested that BPSD are reported in
the prodromal and early stages of DSAD and might predict a
more severe diagnosis. Often, BPSD are reported in the ab-
sence of informant observed functional memory decline (Ball
et al. 2006), in contrast to the presentation of AD in the general
population, where impairments in episodic memory are com-
monly the first reported changes.
The hypothesis that BPSD and executive dysfunction pre-
cede memory issues in the pre-clinical and early stages of AD
in DS is relatively recent (Ball et al. 2006; Adams and Oliver
2010; Kitler et al. 2006; Nelson et al. 2007; Urv et al. 2008;
Määttä et al. 2014; Holland et al. 2000). This systematic re-
view indicates that there is a limited but significant amount of
research supporting the hypothesis, indicating that people with
DS exhibiting BPSD (i.e. those with a history of the onset of
these behaviours as opposed to such behaviours being life-
long) are more likely to decline functionally and on testing
have evidence of impaired executive functioning compared to
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those with no such changes (44% compared to 5.6% of those
without BPSD). Later the impaired group are then more likely
to exhibit memory problems and meet diagnostic criteria for
dementia (Ball et al. 2006). Similarly, in the study conducted
byHolland et al. (2000), younger people with DS, who did not
yet meet the full criteria for a clinical diagnosis of AD, exhib-
ited more ‘frontal-like symptoms’, while older people had
higher rates of clinically diagnosed AD. These results were
supported by Nelson et al. (2007), whose study, although not
identifying any significant decline in function, due to the short
duration between baseline and follow up, argued for the high
reliability and validity of measures of Bfrontal-like symptoms^
in the detection of AD early in the disease process, suggesting
that EF and BPSD may indeed precede or accompany mem-
ory changes in this population
This view is also supported by the results of Holland et al.
(2000). At the time of an initial assessment more participants
were reportedly exhibiting changes in behaviour (46%) than
changes in memory (9%), whereas at follow up. Older partic-
ipants had the largest proportion of reported deteriorations in
memory and personality, whereas younger participants
showed high rates of BPSD in absence of any memory issues,
suggesting a trend of decline from behaviour and personality
to a combination of domains.
This sequential progression of BPSD between various
stages of dementia was further examined in studies that report-
ed correlations between the severity of BPSD and a dementia
diagnosis (Määttä et al. 2014; Urv et al. 2008). If indeed
BPSD are an indicator of dementia development, the question
that arises is whether certain types of behaviours are more
likely to develop. In Urv et al. (2008), participants who
showed cognitive decline insufficient for a diagnosis of AD
exhibited more BPSD directed towards others (i.e. destruc-
tiveness, aggression) than those with a diagnosis of AD,
who exhibited more BPSD directed towards the self (i.e. fear-
fulness, lack of energy, withdrawal, sadness and self-injury).
Interestingly, participants who progressed from no diagnosis
to questionable dementia were more likely to experience a
worsening of scores on certain measures (sadness, increased
dependency, confusion, fearful and regressive behaviour and
social inadequacy), while the scores of people who were
dementia-free at T2 remained relatively stable on these mea-
sures (Urv et al. 2008). Contrary to these findings, Adams and
Oliver (2010) and Makary et al. (2014) suggested a more
positive pattern of ageing than previously reported.
Similarly to the situation described in the case of executive
functioning, a specific pattern of deterioration in BPSD
subdomains is difficult to identify. It was proposed that some
of the earliest signs of dementia in people with DS are ob-
served in language and socialization difficulties (Margallo-
Lana et al. 2007).
Improving our understanding of BPSD and their relation-
ship to AD is essential, given that there are people with DS
with very low levels of cognitive functioning who are unable
to be diagnosed by measures of cognition alone due to floor
levels. This group could, however, be diagnosed on the basis
of BPSD and everyday skills (Margallo-Lana et al. (2007).
Similar conclusions were reached by Cosgrave et al. (2000),
who concluded that even though in their study memory seems
to be the earliest symptom, severe intellectual disability con-
ceals the symptoms and thus, BPSD might be easier to detect
Informant reported BPSD such as social withdrawal, apa-
thy (Ball et al. 2006; Holland et al. 2000), inactivity and lack
of interest (Adams and Oliver 2010), have been reported in all
stages of DSAD (Urv et al. 2008) and it is likely that they
significantly affect activities of daily living, with declines hav-
ing been reported in domestic activity, self-direction and re-
sponsibility (Määttä et al. 2014). However, the authors note
that depression is one of the factors that correlate most strong-
ly with such changes (Urv et al. 2008) and may often act as a
confound due to diagnostic overshadowing (Määttä et al.
2014), alongside hypothyroidism. Because of this potential
confound, caution is advised when discussing the role of
BPSD in the progression of DSAD and these reported changes
must always be analyzed as part of a wider context.
Changes such as restlessness, aggression, repetitive speech
and being uncooperative were most often reported in pre-
clinical and early-stages of AD and thus might represent some
of the earliest observable signs of dementia (Adams and
Oliver 2010). Observation of these signs seems to be more
likely to lead to a referral for dementia assessment and were
shown to emerge alongside cognitive decline. In contrast, Carr
and Collins (2014) in her long-term follow-up of a birth cohort
did not find any increase in aggression with the development
of dementia.
Other BPSD, such as emotional lability, lack of concern for
other people, stubbornness, disinhibition and impulsivity,
were also reported prior to a diagnosis of dementia (Ball
et al. 2006). Stubbornness was the second most reported
BPSD after apathy in a sample of aging people with DS
(Holland et al. 2000), and increases in BPSD were identified
as successful predictors of dementia status. When analyzed
alongside scores for pragnosia, BPSD successfully predicted
over 70% of dementia cases (Nelson et al. 2007). Urv et al.
(2008) suggests that these changes are present before a de-
mentia diagnosis and gradually worsen as dementia pro-
gresses, until late stages of AD when the number of reported
distinct behaviours is reduced.
Activities of Daily Living
Activities of daily living (ADLs) represent a number of activ-
ities such as continence, eating, walking or grooming (Ward
et al. 1998) and have been shown to be a good predictor of
hospital admission and mortality in the elderly population
(Ferrucci et al. 1997). Research has suggested that an indicator
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of the development of AD in people with DS is the loss of
everyday skills and difficulties with activities of daily living
(Margallo-Lana et al. 2007), significantly more affected at age
47, compared to age 30 (Carr and Collins 2014). This pattern
of decline seems to be supported by other research (Cosgrave
et al. 2000) and it has thus been suggested that investigating
ADLs could be very valuable in diagnosing DSAD, especially
in people with severe ID, for whom other changes might be
difficult to notice (Margallo-Lana et al. 2007). However, cau-
tion is advised when interpreting these results, as gender has
been suggested to influence rate of decline in ADL in the
general population (Ward et al. 1998) with women maintain-
ing skills for a longer time in areas such as food preparation,
housekeeping and laundry (Lawton and Brody 1969).
Regarding the hierarchy of loss of ADLs, Cosgrave et al.
(2000) noted that loss of independence in personal hygiene
was among the first signs of dementia, alongside spatial dis-
orientation. The last skills to be lost were eating and shaking
hands, with 86.9% of participants being able to perform this
latter task even in later stages of AD. This is not surprising
given the high baseline for the performance of this behavior
(i.e. at the beginning of the study, 100% of participants with
moderate ID were able to shake hands with the examiner).
However, at the end of the study, many participants were
completely dependent on nursing staff, having many other
difficulties such as incontinence and severe motor difficulties.
Considering the advanced nature of the disease in these par-
ticipants, it is difficult to pinpoint whether loss of a certain
skill is due to loss of social conventions or impaired motor
function. Regardless, more recent studies in the general pop-
ulation do suggest that motor skills should be addressed in
interventions designed for people with AD in order to improve
their daily living (Oakley et al. 2003).
Discussion
Early Signs of Dementia in DS
This review highlights the importance of using a broad spec-
trum of assessments when examining the sequence of decline
of dementia in people with DS, particularly in the early stages
during which the presentation of dementia may differ between
individuals. While there is no overall consensus, there are a
majority of research studies identifying clinical characteristics,
other than the development of functional memory changes
that occur early in the course of AD. However, an evaluation
of the papers included in this systematic review indicates that
assessing the hierarchy of decline that accompanies the devel-
opment of dementia in DS is a challenge. First, from a meth-
odological perspective, change has been identified in two sep-
arate ways, one being a structured informant-based interview
asking specifically about functional changes and the other
being the use of established cognitive tests that can be repeat-
ed over time to established whether there has been a change in
test scores or not. Secondly, as the diagnosis of AD represents
a threshold effect, it is difficult to pinpoint in time the exact
onset of symptoms. Thirdly, heterogeneity of symptoms
seems to be characteristic of the early stages, and inferences
regarding which subdomains of functioning are preferentially
affected are very difficult to make. Fourthly, in people with
DS it is especially difficult to determine whether the observed
symptoms are due to age-related changes in this population or
to preexisting cognitive impairments (Ball et al. 2006). In the
longest longitudinal study included in this review, scores on
the majority of cognitive tests declined by age 47, regardless
of dementia status (Carr and Collins 2014), emphasizing that
researchers must be cautious when interpreting results, as for a
proportion of participants showing this decline it might sug-
gest pre-clinical symptoms of dementia, it might also reflect
normal ageing.
The findings from this systematic review would indicate
that BPSD and impairments in executive functioning mark the
early course of DSAD. Numerous components of executive
function and behavior seem to be affected before memory
skills begin to decline, suggesting that current diagnosis pro-
cedures of AD in DS may not be effective until later stages.
This view is supported by a recent review (Ballard et al. 2016),
which suggested that dementia in DS initially manifests as
BPSD, only to later be followed by changes in cognition.
There are, however, important differences between study
findings that may reflect genuine sample differences or may
be accounted for by differences in methodology. These differ-
ences make an overall picture difficult to ascertain. BPSD and
executive dysfunction were often investigated as part of stud-
ies primarily concerned with cognition whereas memory
changes were reported as part of studies that were carried
out with the intention of confirming the presence of memory
decline. Moreover, some studies only analyzed a restricted
range of abilities and reported on total scores alone, without
specifying the exact area of decline. Given the wide variety of
screening and diagnosis tools in use, as well as recent research
suggesting decline in cognitive function regardless of whether
participants have had a formal diagnosis of dementia, we sup-
port the recent suggestion made by Ballard et al. (2016), that
measures of prevalence reported in published papers should
be interpreted with a degree of caution.
Moreover, as with all neuropsychological testing, there
is overlap in measurement. For example, a decline in a
test of episodic memory would have to be carefully
interpreted if there are poor results on attentional tasks.
Due to this confounding factor, we advise caution when
discussing the results of these papers, as it often is
difficult to establish whether a participant’s decline on
one measure is not influenced by decline in another
related domain.
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Lastly, interpreting results was hindered by the fact that the
majority of studies did not report on the level of intellectual
disability of participants. This issue is essential, considering
that the salience, manifestation and degree of impairment de-
termined by the emergence of AD symptoms can vary accord-
ing to the level of premorbid intellectual capacity and also the
person’s ability to compensate for the newly acquired deficits.
Margallo-Lana et al. (2007) demonstrated that significant cog-
nitive decline at follow - up could only be identified for cases
where the baseline score had been at or above the median
(mild and moderate ID), with little changes being noticeable
for people with severe and profound ID. Moreover, the ma-
jority of studies (Adams and Oliver 2010, Kitler et al. 2006,
Carr and Collins 2014, Cosgrave et al. 2000, Krinsky-McHale
et al. 2002, Nelson et al. 2007, Margallo-Lana et al. 2007,
McCarron et al. 2014, Makary et al. 2014, Määttä et al.
2014) did not document whether dementia was at an early or
advanced stage. As changes in function seem to vary both
quantitatively and qualitatively over the course of AD, future
research should report the stage of decline, as well as age and
IQ.
Recommendations
Given the findings of this review, we believe that establishing
a baseline level of cognitive functioning and behaviour in
people with DS would be extremely useful in following up
on changes in domains known to be affected by AD. We
therefore advocate the development of a set of common mea-
sures appropriate for individuals with DS that would include
in depth evaluation of memory, executive function, language
and behaviour and that can be used both in clinical settings as
well as research. This would allow the implementation of Burt
and Aylward’s model of best practice (Burt and Aylward
2000) which suggests establishing a baseline of premorbid
functioning before the age of 35, having annual reassessments
and conducting a detailed diagnosis in cases where decline is
evident. More research needs to be conducted in order to de-
cide on the exact measures to be included in this tool set, given
the intra-individual variability in task performance in people
with DS (Krinsky-McHale et al. 2008). At present, standard
tools developed for the assessment of cognition in the general
population often show floor effects when administered to in-
dividuals with DS (Stanton and Coetzee 2004) and the major-
ity of the assessment tools are based on the premise that re-
spondents have an IQ in or close to the normative range and
require other skills such as good verbal skills, adequate atten-
tion or dexterity (Prasher et al. 2004). Burt et al. (2005) have
emphasised the need for an appropriate scoring method for
diagnosing dementia in this population and suggested that
slope scores are more useful than difference scores. For exam-
ple, institutionalised individuals with DS are known to score
lower on neuropsychological tests than people living in the
community (Nieuwenhuis-Mark 2009) and thus having an
established baseline and measuring change over time in a
longitudinal follow up design would be a better approach than
cross-sectional studies.
Given that the majority of the studies included in this re-
view point towards BPDS as an early sign of dementia in DS,
we believe that there is an urgent need for the development of
an acceptable, validated and standardised evaluation scale for
BPSD in DS (Sinai et al. 2016), similar to BEHAVE-AD in
the general population (Dekker et al. 2015).
Furthermore, diagnostic and assessment measures devel-
oped for use in the general population are often used in studies
investigating AD in DS, which often introduces confounding
factors (Ballard et al. 2016). This issue was pointed out by
Dekker et al. (2015) who stated that although more than 20
scales have been developed to assess BPSD in AD in the
general population (Finkel 2001), none of these have been
validated in people with DS and therefore are not equally
valuable for use in this population as they do not take into
consideration factors such as pre-existing behavioural issues
associated with ID. In line with the findings of Dekker et al.
(2015), such a scale could be implemented in routine practice
alongside existing assessment procedures which monitor
change over time, as well as being used in longitudinal re-
search and clinical trials.
Having comprehensive assessment tools for outcomes in
clinical trials would enable a targeted approach to drug devel-
opment, which would be essential given recent findings sug-
gesting that people with DS respond differently to treatment
when compared to late-onset AD typically developing con-
trols (Ballard et al. 2016). Moreover, a better understanding
of BPSD in DS would increase acceptance from the perspec-
tive of a carer who would understand that behaviour they
perceive as Bchallenging^ is not deliberate but may be a symp-
tom of dementia (Dekker et al. 2015). Imporved recognition
of symptoms would facilitate access to non-pharmacological
treatments such as behavioural and music therapy and psycho-
social interventions (Gauthier et al. 2010).
To account for the fact that BPSD and executive dysfunc-
tion seem to be affected earlier than episodic memory in the
course of dementia, we suggest Mortimer’s reserve capacity
hypothesis (1981) as a viable theoretical explanation.
According to this model, the frontal lobes of people with DS
are underdeveloped and thus a smaller buden of neuropathol-
ogy in the brain may be required to reach the threshold at
which functioning is impaired. Volume reduction of frontal
lobes has been observed during childhood, while hippocampal
volume reduction has only been reported later in life (Jacola
2012). These observations would account for the preferential
decline in areas of cognition sub-served by these areas.
Indirect support for Mortimer’s reserve capacity hypothesis
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comes from the longitudinal study conducted by Temple et al.
(2001), in which progression of dementia appears to be
slowed by having high levels of pre-morbid cognitive func-
tioning. The authors suggest that environmental interventions
such as improving the level of education and number of years
in employment might represent successful strategies to reduce
cognitive decline. The suggestion that early clinical presenta-
tion of AD in DS matches that of frontal-based symptoms can
serve as a theoretical foundation for the findings of neuroim-
aging studies such as the recent amyloid PET imaging with
18F–FDDNP study that showed increased frontal predomi-
nance of amyloid pathology in people with DS who had a
diagnosis of AD, compared to typically developing patients
with late-onset AD (Nelson et al. 2011).
To conclude, even though there is no overall consensus
on what represents the earliest observable sign of demen-
tia in DS, this review highlights the heterogeneity of af-
fected domains. BPSD, developing for the first time in
later adult life, predicts the subsequent development of
dementia in the majority of the included studies. There
is also evidence that emergence of BPSD is underpinned
by impairments in executive functioning that may impli-
cate impairments in frontal lobe integrity and in related
brain networks (Ball et al. 2008). We recommend that
future research should investigate a wider variety of pro-
cesses, to reflect the heterogeneity of domains that seem
to be affected in the prodromal and early stages of demen-
tia in this population. Moreover, considering that in the
general population amnestic MCI is widely accepted as
the prodromal stage of AD, an alternative should be pro-
posed for people with DS, to reflect this difference in
progression. The key to early diagnosis is knowing what
observed changes should raise the index of suspicion suf-
ficiently to indicate the need for a full diagnostic assess-
ment and cognitive evaluation. The findings of this review
are especially relevant given that current diagnosis proce-
dures (ICD-10 and DSM-V criteria) emphasize declines in
memory functions and therefore in this population may
fail to facilitate the early detection and diagnosis of de-
mentia when it does occur.
Acknowledgments
This systematic review is part of a larger research study
funded by the Baily Thomas Charitable Fund, Addenbrookes
Charitable Trust and the Health Foundation. Queens’ College
Cambridge contributed via a grant which enabled the dissemina-
tion of these findings at BNA 2015 Festival of Neuroscience in
Edinburgh.
Open Access This article is distributed under the terms of the Creative
Commons At t r ibut ion 4 .0 In te rna t ional License (h t tp : / /
creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give
appropriate credit to the original author(s) and the source, provide a link
to the Creative Commons license, and indicate if changes were made.
References
Albert, M., & Cohen, C. (1992). The Test for Severe Impairment: an
instrument for the assessment of patients with severe cognitive dys-
function. Journal of the American geriatrics society, 40(5), 449–
453.
Adams, D., & Oliver, C. (2010). The relationship between acquired im-
pairments of executive function and behaviour change in adults with
down syndrome. Journal of Intellectual Disability Research, 54,
393–405.
American Psychiatric Association. (2013). Diagnostic and statistical
manual of mental disorders (5th ed.). DC: Washington.
Annus, T., Wilson, L. R., Hong, Y. T., Acosta–Cabronero, J., Fryer, T. D.,
Cardenas–Blanco, A., ... & Menon, D. K. (2015). The pattern of
amyloid accumulation in the brains of adults with down syndrome.
Alzheimer's & Dementia.
Ball, S. L., Holland, A. J., Huppert, F. A., Treppner, P., Watson, P., &
Hon, J. (2004). The modified CAMDEX informant interview is a
valid and reliable tool for use in the diagnosis of dementia in adults
with Down’s syndrome. Journal of Intellectual Disability Research,
48(6), 611–620.
Ball, S. L., Holland, A. J., Hon, J., Huppert, F. A., Treppner, P., &Watson,
P. C. (2006). Personality and behaviour changes mark the early
stages of Alzheimer's disease in adults with down syndrome: find-
ings from a prospective population-based study. Int. J. Geriat.
Psychiatry, 21, 661–673.
Ball, S. L., Holland, A. J., Treppner, P., Watson, P. C., & Huppert, F. A.
(2008). Executive dysfunction and its association with personality
and behaviour changes in the development of Alzheimer's disease in
adults with down syndrome and mild to moderate learning disabil-
ities. British Journal of Clinical Psychology, 47(1), 1–29.
Ballard, C., Mobley, W., Hardy, J., Williams, G., & Corbett, A. (2016).
Dementia in Down's syndrome. The Lancet Neurology, 15(6), 622–
636.
Beery, K. E., Buktenica, N. A., & Beery, N. A. (1997). The Beery-
Buktenica developmental test of visual-motor integration: VMI, with
supplemental developmental tests of visual perception and motor
coordination: administration, scoring and teaching manual.
Parsippany, NJ: Modern Curriculum Press.
Benejam, B., Fortea, J., Molina-López, R., & Videla, S. (2015). Patterns
of performance on the modified cued recall test in Spanish adults
with down syndrome with and without dementia. American Journal
of Intellectual and Developmental Disabilities, 120(6), 481–489.
Bittles, A. H., & Glasson, E. J. (2004). Clinical, social, and ethical impli-
cations of changing life expectancy in down syndrome.
Developmental Medicine & Child Neurology, 46(4), 282–286.
Burt, D. B., & Aylward, E. H. (2000). Test battery for the diagnosis of
demntia in individuals with intellectual disability. Journal of
Intellectual Disability Research, 44(2), 175–180.
Burt, D. B., Primeaux-Hart, S., Loveland, K. A., Cleveland, L. A., Lewis,
K. R., Lesser, J., & Pearson, P. L. (2005). Comparing dementia
diagnostic methods used with people with intellectual disabilities.
Journal of Policy and Practice in Intellectual Disabilities, 2(2), 94–
115.
Buschke, H. (1973). Selective reminding for analysis of memory and
learning. Journal of Verbal Learning and Verbal Behavior, 12(5),
543–550.
Buschke, H. (2008). Cued recall in amnesia. Journal of Clinical
Neuropsychology, 6(4), 433–440.
Neuropsychol Rev (2017) 27:31–45 43
Carr, J., & Collins, S. (2014). Ageing and dementia in a longitudinal
study of a cohort with down syndrome. Journal of Applied
Research in Intellectual Disabilities, 27, 555–563.
Cosgrave, M. P., Tyrrell, J., McCarron, M., Gill, M., & Lawlor, B. A.
(2000). A five year follow-up study of dementia in persons with
down syndrome: early symptoms and patterns of deterioration.
Irish Journal of Psychological Medicine, 17(01), 5–11.
Deb, S., Hare, M., & Prior, L. (2007). Symptoms of dementia among
adults with down syndrome: a qualitative study. Journal of
Intellectual Disability Research, 51, 726–739.
Dekker, A. D., Strydom, A., Coppus, A. M., Nizetic, D., Vermeiren, Y.,
Naudé, P. J., et al. (2015). Behavioural and psychological symptoms
of dementia in down syndrome: early indicators of clinical
Alzheimer's disease? Cortex, 73, 36–61.
Devenny, D. A., Krinsky-McHale, S. J., Sersen, G., & Silverman, W. P.
(2000). Sequence of cognitive decline in dementia in adults with
down syndrome. Journal of Intellectual Disability Research,
44(6), 654–665.
Dunn, D. M., & Dunn, L. M. (2007). Peabody picture vocabulary test:
Manual. Minneapolis, MN: Pearson.
Dunn, L. M., & Dunn, D. M. (2009). The British picture vocabulary
scale. London: GL Assessment Limited.
Evenhuis, H. M., Eurlings, H. A. L., & Kengen, M. M. F. (1990).
Dementia Questionnaire for Mentally Retarded Persons (DMR):
For Diagnosis of Dementia in Mentally Retarded People-1990.
The Netherlands: Hooge Burch Institute for Mentally Retarded
People.
Ferrucci, L., Guralnik, J. M., Pahor, M., Corti, M. C., & Havlik, R. J.
(1997). Hospital diagnoses, Medicare charges, and nursing home
admissions in the year when older persons become severely dis-
abled. JAMA, 277(9), 728–734.
Finkel, S. I. (2001). Behavioral and psychological symptoms of demen-
tia: a current focus for clinicians, researchers, and caregivers. The
Journal of Clinical Psychiatry, 62(Suppl. 2), 3–6.
Fuld, P. A. (1981). The Fuld object memory test. Chicago: The Stoelting
Instrument Company.
Gauthier, S., Cummings, J. L., Ballard, C., Brodaty, H., Grossberg, G.,
Robert, P., et al. (2010). Management of behavioral problems in
Alzheimer's disease. International Psychogeriatrics/IPA, 22(3),
346e372.
Gedye, A. (1995). Dementia scale for Down syndrome manual.
Vancouver: Gedye Research and Consulting.
Gerstadt, C. L., Hong, Y. J., & Diamond, A. (1994). The relationship
between cognition and action: performance of children 312–7 years
old on a stroop-like day-night test. Cognition, 53(2), 129–153.
Goldstein, K., & Scheerer, M. (1941). Abstract Psychological
Monographs, 53(2), i.
Hartley, D., Blumenthal, T., Carrillo, M., DiPaolo, G., Esralew, L.,
Gardiner, K., et al. (2014). Down syndrome and Alzheimer's dis-
ease: common pathways, common goals. Alzheimer's & Dementia,
1–10.
Haxby, J. V. (1989). Neuropsychological evaluation of adults with
Down’s syndrome: patterns of selective impairment in non-dement-
ed old adults. Journal of Intellectual Disability Research, 33(3),
193–210.
Holland, A. J., Hon, J., Huppert, F. A., & Stevens, F. (2000). Incidence
and course of dementia in people with down syndrome: findings
from a population-based study. Journal of Intellectual Disability
Research, 44, 138–146.
Jacola, L. M. (2012). The relationship between executive function and
maladaptive behavior in adolescents with down syndrome.
Unpublished doctoral dissertation. University of Cincinnati, Ohio.
Jastak, S., & Wilkinson, G. S. (1984). The wide range achievement test-
revised. Jastak Associates.
Kalsy, S., McQuillan, S., Oliver, C., Hall, S., & Oyebode, J. (2002). The
adults with Down’s Syndrome Project: The Assessment of Adults
with Developmental Disabilities (AADS) Questionnaire.
Birmingham: University of Birmingham & South Birmingham
Primary Care NHS Trust.
Kaplan, E., Goodglass, H., & Weintraub, S. (2001). Boston naming test.
Austin: Pro-ed.
Kitler, P., Krinsky-McHale, S. J., & Devenny, D. A. (2006). Verbal intru-
sions precede memory decline in adults with down syndrome.
Journal of Intellectual Disability Research, 50, 1–10.
Kittler, P., Krinsky-McHale, S. J., & Devenny, D. A. (2004). Semantic
and phonological loop effects on verbal workingmemory in middle-
age adults with mental retardation. American Journal on Mental
Retardation, 109(6), 467–480.
Krikorian, R., Bartok, J., & Gay, N. (1994). Tower of London procedure:
a standard method and developmental data. Journal of clinical and
Experimental Neuropsychology, 16(6), 840–850.
Krinsky-McHale, S. J., Devenny, D. A., & Silverman, W. P. (2002).
Changes in explicit memory associatedwith early dementia in adults
with down syndrome. Journal of Intellectual Disability Research,
46(3), 198–208.
Krinsky-McHale, S. J., Devenny, D. A., Kittler, P., & Silverman,
W. (2008). Selective attention deficits associated with mild
cognitive impairment and early stage Alzheimer's disease in
adults with down syndrome. American Journal on Mental
Retardation, 113(5), 369–386.
Lai, F., & Williams, R. S. (1989). A prospective study of Alzheimer’s
disease in down syndrome. Archives of Neurology, 46, 849–853.
Lawton, M. P., & Brody, E. M. (1969). Assessment of older people: self-
maintaining and instrumental activities of daily living.
Gerontologist, 9, 179–186.
Leiter, R. G. (1940). The Leiter international performance scale (Vol. 1).
Barbara: Santa Barbara State College Press.
Määttä, T., Tervo-Määttä, T., Taanila, A., Kaski, M., & Iivanainen, M.
(2014). Adaptive Behaviour Change and Health in Adults with
Down Syndrome: A prospective clinical follow-up study,
Pharmacology and Nutritional Intervention in the Treatment of
Disease, Dr. Faik Atroshi (Ed.), Finland.
Makary, A. T., Testa, R., Einfeld, S. L., Tonge, B. J., Mohr, C., &Gray, K.
M. (2014). The association between behavioural and emotional
problems and age in adults with DS without dementia: examining
a wide spectrum of behavioural and emotional problems. Research
in Developmental Disabilities, 35(8), 1868–1877.
Margallo-Lana, M. L., Moore, P. B., Kay, D.W. K., Perry, R. H., Reid, B.
E., Berney, T. P., & Tyrer, S. P. (2007). Fifteen-year follow-up of 92
hospitalized adults with down syndrome: incidence of cognitive
decline, its relationship to age and neuropathology. Journal of
Intellectual Disability Research, 51, 463–477.
McCarron, M., McCallion, P., Reilly, E., & Mulryan, N. (2014).
A prospective 14-year longitudinal follow-up of dementia in
persons with down syndrome. Journal of Intellectual
Disability Research, 58(1), 61–70.
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T.,
Jack, C. R., Kawas, C. H., et al. (2011). The diagnosis of
dementia due to Alzheimer’s disease: recommendations from
the National Institute on Aging-Alzheimer’s association
workgroups on diagnostic guidelines for Alzheimer's disease.
Alzheimer's & Dementia, 7(3), 263–269.
Mohr, C., Tonge, B. J. & Einfeld, S. L. (2004). Manual for the
Developmental Behaviour Checklist-Adult Version, Melbourne and
Sydney, Australia: Monash University Centre for Developmental
Psychiatry and Psychology and School of Psychiatry, University of
New South Wales.
Mortimer, J. A., Schuman, L., & French, L. (1981). Epidemiology of
dementing illness. In J. A. Mortimer & L. M. Schuman (Eds.), The
epidemiology of dementia: Monographs in epidemiology and
biostatistics (pp. 323–333). New York: Oxford University Press.
44 Neuropsychol Rev (2017) 27:31–45
National Institute of Aging. National Institute of Aging, Laboratory of
Neurosciences; 1989. The daily living skills questionnaire.
Nelson, L. D., Scheibel, K. E., Ringman, J. M., & Sayre, J. M.
(2007). An experimental approach to detecting dementia in
down syndrome: a paradigm for Alzheimer’s disease. Brain
and Cognition, 64, 92–103.
Nelson, L. D., Siddarth, P., Kepe, V., Scheibel, K. E., Huang, S. C.,
Barrio, J. R., & Small, G. W. (2011). Positron emission tomography
of brain β-amyloid and tau levels in adults with down syndrome.
Archives of Neurology, 68(6), 768–774.
Nieuwenhuis-Mark, R. E. (2009). Diagnosing Alzheimer's dementia in
down syndrome: problems and possible solutions. Research in
Developmental Disabilities, 30(5), 827–838.
Oakley, F., Duran, L., Fisher, A., & Merritt, B. (2003). Differences in
activities of daily living motor skills of persons with and without
Alzheimer's disease. Australian Occupational Therapy Journal,
50(2), 72–78.
Prasher, V., Farooq, A., & Holder, R. (2004). The adaptive behaviour
dementia questionnaire (ABDQ): screening questionnaire for de-
mentia in Alzheimer’s disease in adults with down syndrome.
Research in Developmental Disabilities, 25, 385–397.
Reiss, S. (1994). Reiss screen for maladaptive behavior: test manual.
Worthington: IDS Publishing.
Sabbagh, M., & Edgin, J. (2016). Clinical assessment of cognitive decline in
adults with down syndrome.Current Alzheimer Research, 13(1), 30–34.
Silverman, W. (2007). Down syndrome: cognitive phenotype. Mental
Retardation and Developmental Disabilities Research Reviews,
13(3), 228–236.
Sinai, A., Hassiotis, A., Rantell, K., & Strydom, A. (2016). Assessing
specific cognitive deficits associated with dementia in older adults
with down syndrome: use and validity of the Arizona cognitive test
battery (ACTB). PloS One, 11(5), e0153917.
Sparrow, S. S., Balla, D. A., Cicchetti, D. V., Harrison, P. L., &Doll, E. A.
(1984). Vineland adaptive behavior scales. Circle Pines: American
Guidance Service.
Stanton, L. R., & Coetzee, R. H. (2004). Down’s syndrome and dementia.
Advances in Psychiatric Treatment, 10, 50–58.
Strauss, H., & Lewin, I. (1982). An empirical study of the weigl-gold-
stein-scheerer color-form test according to a developmental frame of
reference. Journal of clinical Psychology, 38(2), 367–375.
Strydom, A., Shooshtari, S., Lee, L., Raykar, V., Torr, J., Tsiouris, J., et al.
(2010). Dementia in older adults with intellectual disabilities—epi-
demiology, presentation, and diagnosis. Journal of Policy and
Practice in Intellectual Disabilities, 7(2), 96–110.
Suarez-Almazor, M. E., Belseck, E., Homik, J., Dorgan, M., & Ramos-
Remus, C. (2000). Identifying clinical trials in the medical literature
with electronic databases: MEDLINE alone is not enough.
Controlled Clinical Trials, 21(5), 476–487.
Temple, V., Jozsvai, E., Konstantareas, M. M., & Hewitt, T. A. (2001).
Alzheimer dementia in down syndrome: the relevance of cognitive
ability. Journal of Intellectual Disability Research, 45, 47–55.
Urv, T. K., Zigman, W. B., & Silverman, W. (2008). Maladaptive behav-
iours related to dementia status in adults with down syndrome.
Americal Journal on Mental Retardation, 2, 73–86.
Ward, G., Jagger, C., &Harper,W. (1998). A review of instrumental ADL
assessments for use with elderly people. Reviews in Clinical
Gerontology, 8(01), 65–71.Zeng, X., Zhang, Y., Kwong, J. S. W.
Wechsler, D. (1967). Manual for the Wechsler preschool and primary
scale of intelligence. San Antonio: Psychological Corporation.
Wechsler, D. (1974).Manual for the Wechsler intelligence scale for chil-
dren, revised. San Antonio, TX: Psychological Corporation.
Wilson, B. A., & Ivani-Chalian, R. (1995). Performance of adults with
Down’s syndrome on the children’s version of the Rivermead be-
havioural memory test: a brief report. British journal of clinical
psychology, 34(1), 85–88.
Wing, L. (1980). The MRC handicaps, behaviour & skills (HBS) sched-
ule. Acta Psychiatrica Scandinavica, 62(S285), 241–248.
Wisniewski, H. M., & Hill, A. L. (1985). Clinical aspects of dementia in
mental retardation and developmental disabilities. In M. P. Janicki &
H. M. Wisniewski (Eds.), Aging and developmental disabilities (pp.
195–207). Baltimore: Brookes.
Zeng, C., Zhang, C., Li., S., et al. (2015). The methodological quality
assessment tools for preclinical and clinical studies, systematic re-
view and meta-analysis, and clinical practice guideline: a systematic
review. Journal of Evidence Based. Medicine, 8, 2–1
Neuropsychol Rev (2017) 27:31–45 45
